Skip to main content
Premium Trial:

Request an Annual Quote

Avellino Labs Receives FDA Emergency Use Authorization for Coronavirus Test

NEW YORK – Avellino Labs on March 25 received Emergency Use Authorization for its coronavirus real-time PCR diagnostic test from the US Food and Drug Administration.

The assay, called AvellinoCoV2 test, is designed for the detection of nucleic acid from SARS-CoV-2, the virus that causes COVID-19, from nasopharyngeal and oropharyngeal swab specimens from individuals suspected by their healthcare provider of being infected with the virus.

According to the EUA, the test may only be performed by Avellino's CLIA laboratory. The company is based in Menlo Park, California.

Last fall, Avellino received CLIA certification for its lab, enabling it to process samples for its AvaGen sequencing test for keratoconus and corneal dystrophies.

 

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.